Source non-cytotoxic pharmaceutical waste from manufacturing and healthcare. Solvent recovery and co-processing routes. Connect with licensed receivers via SymbioFlows.
~500k t/yr
EU annual generation
Cost €150–600/t depending on classification
Typical market range
18 01 09
Primary EWC classification
| # | Route | Buyer Type | Price Range |
|---|---|---|---|
| 1 | Co-processing in cement kiln | Cement producers (licensed) | Cost €150–300/t |
| API residues with CV >15 MJ/kg accepted; inorganic content enters clinker | |||
| 2 | High-temperature incineration | Licensed hazardous waste incinerators | Cost €250–600/t |
| Required for cytotoxic, hormone-active, or unclassified API waste | |||
| 3 | Solvent recovery (production solvents) | Solvent re-distillers | Credit €200–600/t for pure streams |
| Applicable to production solvent streams — not end-of-life medicines | |||
Primary code: 18 01 09
How pharma waste fits into a wider valorisation strategy.
Your pharma waste stream is assessed against chemistry, waste classification and proven recovery routes — graded results in your browser in seconds. No call, no commitment.
Recovery tiers only. For numbers that survive a technical review, see the validation dossier.